Status:
WITHDRAWN
Statin InTensity to Prevent Coronary Artery Vasculopathy After Heart Transplantation
Lead Sponsor:
Montefiore Medical Center
Conditions:
Vasculopathy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The investigator's propose to conduct an open-label randomized controlled trial to determine if higher intensity statin (HS) can reduce CAV in comparison to lower intensity statin (LS) after HT. All c...
Detailed Description
Outcomes after heart transplantation (HT) are limited by development of coronary allograft vasculopathy (CAV). CAV comprises of macro- and microvascular coronary disease and is the third leading cause...
Eligibility Criteria
Inclusion
- Waitlisted for Heart Transplantation
- Capacity to provide informed consent
Exclusion
- History of statin allergy or intolerance
- Hepatic dysfunction
- Redo Heart Transplant
- Awaiting combined heart and liver transplantation
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2030
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05251129
Start Date
January 1 2025
End Date
June 1 2030
Last Update
January 13 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.